Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

News SummaryMost relevantAll newsSector newsTweets 

CYANOTECH : Michael A. Davis Named Chairman of the Board of Directors of Cyanotech

share with twitter share with LinkedIn share with facebook
share via e-mail
04/21/2011 | 02:10pm CET

Michael A. Davis has been elected as Chairman of the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces Gregg Robertson, who resigned in late 2010.

Mr. Davis was Vice-Chairman of the Board and has been a Director of Cyanotech since March 2003.

"Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years," said Brent Bailey, President and CEO. "We look forward to his continuing support and leadership as Chairman of the Board."

Mr. Davis, a private Investor and major shareholder of Cyanotech since 1994, is also President of Skywords Family Foundation and a Director of Canobie Films, Inc.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®--all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

Cyanotech Corporation
Bruce Russell, 310-559-4955 x101

© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CYANOTECH CORP
2016 CYANOTECH CORPORATION (NASDAQ : CYAN) Files An 8-K Submission of Matters to a Vo..
2016 CYANOTECH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
2016 COSTCO WHOLESALE : Having item in Costcos helps Cyanotech lift net
2016 CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
2016 CYANOTECH : Reports Financial Results for the Second Quarter and First Six Month..
2016 CYANOTECH CORP : Change in Directors or Principal Officers, Financial Statements..
2016 CYANOTECH : Names Nancy Katz as a Director
2016 CYANOTECH : reg; Corporation Earns Non-GMO Project Verification for BULK SCE Bio..
2016 CYANOTECH CORP : Other Events (form 8-K)
2016 CYANOTECH CORP : Entry into a Material Definitive Agreement, Creation of a Direc..
More news
Sector news : Biopharmaceuticals
01/23 U.S. FTC reaches pay-for-delay settlement with Endo
01/20 European shares ease ahead of Trump inauguration
01/20 Bristol-Myers shares fall on lung cancer timeline setback
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
More sector news : Biopharmaceuticals
News from SeekingAlpha
2016 Cyanotech reports FQ2 results
2016 Cyanotech reports FQ1 results
2016 Cyanotech revenues off 4% in FQ4
2016 Cyanotech reports FY16 results
2016 INSIDERINSIGHTS.COM DAILY ROUND UP 4 : Cyan, wlh, smlp, vtvt
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Full-screen chart
Gerald R. Cysewski President, Chief Executive Officer & Director
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Walter B. Menzel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOGEN INC-1.03%61 064
CSL LIMITED14.13%39 470
GRIFOLS SA2.83%13 265
More Results